No Detail Found!

Admission due to Malignant Neoplasm of Eye and Adnexa in Australia: A Time-Trend Analysis

Author(s)
Dina M. Abdulmannan College of Medicine, Umm Alqura University, Makkah, Saudi Arabia
Abdallah Y. Naser Department of Applied Pharmaceutical Sciences and Clinical Pharmacy, Faculty of Pharmacy, Isra University, Amman, Jordan
Abstract
Background: Malignant neoplasms are common and are associated with multiple complications that require hospital admissions. Therefore, this study aimed to investigate trends in hospital admissions for eye cancer in Australia. Methods: This is a time trend analysis study used data from the National Hospital Disease Database for the durations between 1998 and 2023. Admissions related to malignant neoplasm of eye and adnexa were identified using relevant ICD codes (C69). Results: Over the 25 years from 1998/1999 to 2022/2023, Australia recorded 18,679 hospitals admissions due to “malignant neoplasm of eye and adnexa”. Besides, 51.2% (9,556) of these admissions were overnight and 48.8% (9,123) were same-day. From 1998/1999 to 2022/2023, there was a 53.0% increase in the overall number of admissions from 624 to 955, a 62.2% increase in same-day admissions from 275 to 446 and a 45.8% increase in overnight admissions from 349 to 509. Age group 0-14 years accounted for 41.3% or 7,720 of total admissions and males accounting for 54.3% or 10,137 of total admissions. A total of 74.1% of these admissions were due to “malignant neoplasm of retina”. Conclusion: Our study found several significant findings related to trends in hospital admissions due to “malignant neoplasm of eye and adnexa” in Australia. Younger people (less than 15 years old) represented the largest age group of patients admitted to the hospital during the study period; therefore, admissions due to “malignant neoplasm of retina” were the most common diagnoses. Thus, there is a need to implement interventions aimed at reducing hospital admissions due to “malignant neoplasm of eye and adnexa,” particularly for young people and males.
Publication Details
Page(s) 79-85
DOI DOI not available
Published Journal: Journal of Pioneering Medical Sciences, Volume: 15, Issue: 3, Year: 2026

Request the full text from PASTIC

Keywords
Eye, Cancer, Neoplasm, Australia, Admission, Adnexa
References
Alfaar A.S. . .Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body.” Graefe's Archive for Clinical and Experimental Ophthalmology. , 259(2021) : 515-526.
Templeton A.C. .1973 .Tumours of the Eye and Adnexa.” Tumours in a Tropical Country: A Survey of Uganda 1964-1968. , : 203-214.
Hazazi A. .2024 .From diagnosis to therapy: the transformative role of lncRNAs in eye cancer management. ” Pathology Research and Practice, 254 : .
Hsu W.M. . .Incidence of eye cancer in Taiwan: an 18-year review. ” Eye, 18(2004) : 152-158.
Kivelä T. . .The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. British Journal of Ophthalmology, 93(2009) : 1129-1131.
Sullivan R. .2011 .Delivering affordable cancer care in highincome countries. The Lancet Oncology, 12(10) : 933-980.
Tan S. .2020 .Cancer immunotherapy: pros, cons and beyond. ” Biomedicine and Pharmacotherapy, 124 : .
Padma V.V. . .An overview of targeted cancer therapy. ” Biomedicine (Taipei), 5(2015) : 19.
Chalkidou K. . .Evidence-informed frameworks for costeffective cancer care and prevention in low, middle and highincome countries. The Lancet Oncology, 15(2014) : e119-e131.
Dimas K. .2015 .Cancer of the Eye (Intraocular Cancer). ” Reference Module in Biomedical Sciences, Elsevier, : .
Lee S.B. . .Eye cancer incidence in Singapore. British Journal of Ophthalmology, 84(2000) : 767-770.
Naser A.Y. .2022 .Trends in hospital admissions due to neoplasms in England and Wales between 1999 and 2019: an ecological study. International Journal of Environmental Research and Public Health, 19 : .
Hassanin F.F. .2024 .Eye and adnexa hospitalization in Australia: an ecological study. ” Medicine, 103(27) : .
Huang J. . .Disease burden, risk factors and temporal trends of eye cancer: a global analysis of cancer registries. ” Clinical and Experimental Ophthalmology, 52(2024) : 440-451.
Hassan W.M. . .Orbital tumors in USA: difference in survival patterns. ” Cancer Epidemiology, 38(2014) : 515-522.
.2024 .. [16] Australian Bureau of Statistics. About the Australian Bureau of Statistics. 2024. Accessed 30 November, : .
Population Territory,November Territory .2024 .. , : .
November .2024 .Australian Institute of Health and Welfare. National Hospitals Data Collection, : .
.2024 .Australian Institute of Health and Welfare. About the Data. 2024. Accessed 30 November, : .
Boulos P.R.,Rubin P.A. . .Cutaneous melanomas of the eyelid. , 21(2006) : 195-206.
Shields J.A.,Shields C.L. . .Sebaceous adenocarcinoma of the eyelid. International Ophthalmology Clinics, 49(2009) : 45-61.
Jager M.J. . .Uveal melanoma. Nature Reviews Disease Primers, 6(2020) : 24.
Ataeinia B. .2021 .National and subnational incidence, mortality and years of life lost due to breast cancer in Iran: trends and age-period-cohort analysis since. , 11 : 561376.
Kaliki S.,Shields C.L. . .Uveal melanoma: relatively rare but deadly cancer. ” Eye, 31(2017) : 241-257.
Basti S.,Macsai M.S. . .Ocular surface squamous neoplasia: a review. ” Cornea, 22(2003) : 687-704.
Walpole S. .2018 .Comprehensive study of the clinical phenotype of germline BAP1 variant-carrying families worldwide. ” Journal of the National Cancer Institute, 110(12) : 1328-1341.
Krantz B.A. .2017 .Uveal melanoma: epidemiology, etiology and treatment of primary disease. ” Clinical Ophthalmology, 11 : 279-289.
Kaur K.,Patel B.C. .2025 .. , : .
Al-Zomia Saad,A. Saad .2023 .A retrospective study of ocular cancer in Saudi Arabia: 25-year analysis. ” Clinical Ophthalmology, 17 : 3103-3111.
Watmon B. .2020 .Malignant ocular and adnexal neoplasms in Gulu Regional Referral Hospital. The Journal of Ophthalmology of Eastern, Central and Southern Africa, 24(1) : .
Domingo R.E. . .Tumors of the eye and ocular adnexa at the Philippine Eye Research Institute: a 10-year review. ” Clinical Ophthalmology, 9(2015) : 1239-1247.
Bai S. . .Delay in the diagnosis of retinoblastoma in China. ” Acta Ophthalmologica, 89(2011) : e72-e74.
Mattosinho C.C.S. . .Time to diagnosis of retinoblastoma in Latin America: a systematic review. ” Pediatric Hematology and Oncology, 36(2019) : 55-72.
Faranoush M. . .Consequences of delayed diagnosis in treatment of retinoblastoma. Iranian Journal of Pediatrics, 24(2014) : 381-386.
Wirix M. .2000 .Delayed diagnosis of retinoblastoma. , (278) : 37-41.
Nag A.,Khetan V. . .Retinoblastoma-A comprehensive review. update and recent advances.” Indian Journal of Ophthalmology, 72(2024) : 778-788.
Soliman S.E. . .Clinical presentation of retinoblastoma in Alexandria: a step toward earlier diagnosis. Saudi Journal of Ophthalmology, 31(2017) : 80-85.
Sherief S.T. . .Referral patterns for retinoblastoma patients in Ethiopia. ” BMC Health Services Research, 23(2023) : 172.
Tomar A.S. .2020 .A multicenter, international collaborative study for American Joint Committee on Cancer staging of retinoblastoma: part I: metastasis-associated mortality. ” Ophthalmology, 127(12) : 1719-1732.
Tian Y. .2015 .Radioactive (125)I seeds inhibit cell growth and epithelial-mesenchymal transition in human glioblastoma multiforme via a ROS-mediated signaling pathway. ” BMC Cancer, 15 : 1.
Wazir M.I. and S.,Karim M.I. and S. . .Causes of delayed presentation of retinoblastoma: a single centre study. International Journal of Health Sciences, 7(2023) : 3207-3213.
Naser A.Y. . .Knowledge and awareness of the general population and healthcare providers about retinoblastoma: it is time to know the glow. International Journal of Clinical Practice, 75(2021) : e14298.
Green A.L. . .Correlation of insurance, race and ethnicity with pathologic risk in a controlled retinoblastoma cohort. ” Ophthalmology, 123(2016) : 1817-1823.
Wong E.S. . .Global retinoblastoma survival and globe preservation: a systematic review and meta-analysis of associations with socioeconomic and health-care factors. ” The Lancet Global Health, 10(2022) : e380-e389.
Jullien S. . .Vision screening in newborns and early childhood. ” BMC Pediatrics, 21(2021) : 306.
Li C. .2021 .Global, regional and national burden due to retinoblastoma in children aged younger than 10 years from. , 22(2024) : 604.
Suarez M.J. “,Medina M.J. “ .2016 .Choroidal metastases.” Manual of Retinal Diseases: A Guide to Diagnosis and Management, edited by C.A. , : 197-200.
Zhang W. . .Global incidence and prevalence of malignant orbital tumors. ” Advances in Ophthalmology Practice and Research, 4(2024) : 128-133.
Asadi-Amoli F.,Ghanadan A. .2015 .Survey of 274 patients with conjunctival neoplastic lesions in Farabi Eye Hospital. ” Journal of Current Ophthalmology, 27(1-2) : 37-40.
Vajdic C.M. .1998 .Incidence of ocular melanoma in Australia from. International Journal of Cancer, 105(2003) : 117-122.
Alrawashdeh H.M. .2022 .Trends in hospital admission due to diseases of the eye and adnexa in the past two decades in England and Wales: an ecological study. International Journal of General Medicine, 15 : 1097-1110.
Evans R.E. . .Gender differences in early detection of cancer. ” Journal of Men's Health and Gender, 2(2005) : 209-217.
Bayram C. . .General practice encounters with men. ” Australian Family Physician, 45(2016) : 171-174.
.2012 .. , : .
0

Citations

0

Downloads

16

Views